CVS Health's poor 2024 performance could be turning around in 2025 with a new CEO and potential rebound, despite challenges.

As pharmaceutical breakthroughs offer new treatment options, people are paying more attention to the coverage their employers ...

Shares of insurers and pharmacy benefit manager (PBM) companies such as Centene, Elevance Health, Humana and CVS Health are ...

During an earnings call on Friday, Walgreens CEO Tim Wentworth made a startling admission about the effects of locking up ...

The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...

The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts—marked up prices at their pharmacies by hundreds or thousands ...

VECV unveils its latest sustainable and smart mobility solutions, including electric coaches and innovative transport ...

CVS Health (CVS) closed at $51.96 in the latest trading session, marking a -0.35% move from the prior day. This move lagged the S&P 500's daily loss of 0.21%. Elsewhere, the Dow lost 0.16%, while the ...

UnitedHealth, in which slain CEO Brian Thompson was employed, has been allegedly accused of overcharging patients suffering ...

There are big, complex, significant, impactful prosecutions out there,” U.S. Attorney Zachary Cunha said. He plans to stay on ...

But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it ...